(UNC Lineberger) Feb 22, 2017 - UNC Lineberger researchers Hy Muss, MD, Shlomit Strulov Shachar, MD, and colleagues report in the journal Clinical Cancer Research that a measure of muscle mass and muscle quality developed at UNC could potentially help doctors better identify patients at high risk for side effects that could require...
(Yahoo! Finance) Feb 23, 2017 - Rexahn Pharmaceuticals, Inc., today announced that is has begun enrolling patients into a Phase IIa clinical study of Supinoxin™ in metastatic triple negative breast cancer (TNBC). The study will evaluate the safety and efficacy of Supinoxin™ in patients with metastatic TNBC who have failed prior...
There are no Breast OBR Green articles.